癌症转移中的微管子动态:利用治疗干预的低估潜力
Snehal Mangaonkar1, Sangeeta Nath1, Biswa Prasun Chatterji2
1Manipal Institute of Regenerative Medicine, Bangalore, Manipal Academy of Higher Education, Manipal, India.
Pharmacology & therapeutics
|September 30, 2024
概括
向微管体的药物显示出通过直接影响微管体或通过替代途径抑制癌症转移的希望. 新兴的疗法,如HDAC抑制剂和抗体-药物联合体,提供了新的策略来防止癌症的传播.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 微管是动态的细胞骨结构,对细胞功能至关重要.
- 癌症的进展和转移受到微管子动态的显著影响.
- 向微管体的药物正在成为针对癌症转移的新疗法策略.
研究的目的:
- 综合审查向微管类药物及其在抑制癌症转移方面的潜力.
- 探索这些药物的抗转移性作用的机制.
- 讨论新兴药物类及其治疗潜力.
主要方法:
- 对微管向剂的体外和体内研究的综述.
- 分析各种化合物的细胞毒性和抗转移剂量.
- 讨论基斯脱乙酶 (HDAC) 抑制剂和抗体-药物联合体.
主要成果:
- 微管向药物表现出直接和间接的抗转移效应.
- HDAC 抑制剂通过影响微管类乙化来表现出抗转移性质.
- 微管向剂的新型抗体结合物在临床试验中显示出抗转移潜力.
结论:
- 微管是癌症转移的关键调节者,提供治疗点.
- HDAC 抑制剂和抗体-药物联合体代表了对抗转移治疗的有希望的途径.
- 了解微管与其他细胞骨蛋白的交叉交互可以导致创新的转移抑制策略.
相关概念视频
Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Microtubule Instability
5.0K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.0K
Microtubule Formation
5.5K
Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
5.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


